Literature DB >> 2214612

Ciclosporin-propafenone interaction.

C H Spes1, C E Angermann, K Horn, T Strasser, H Mudra, R Landgraf, K Theisen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2214612     DOI: 10.1007/bf01662785

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  3 in total

Review 1.  An appraisal of drug interactions with Sandimmun.

Authors:  I T Cockburn; P Krupp
Journal:  Transplant Proc       Date:  1989-10       Impact factor: 1.066

2.  Cyclosporin. Pharmacokinetics and metabolism.

Authors:  M Lemaire; G Maurer; A J Wood
Journal:  Prog Allergy       Date:  1986

3.  Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.

Authors:  L A Siddoway; K A Thompson; C B McAllister; T Wang; G R Wilkinson; D M Roden; R L Woosley
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

  3 in total
  4 in total

Review 1.  Genetically determined adverse drug reactions involving metabolism.

Authors:  M S Lennard
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

2.  Characterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoprotein.

Authors:  Iouri Bachmakov; Sabine Rekersbrink; Ute Hofmann; Michel Eichelbaum; Martin F Fromm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04-15       Impact factor: 3.000

Review 3.  Antiarrhythmic agents: drug interactions of clinical significance.

Authors:  T C Trujillo; P E Nolan
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

Review 4.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.